ArticleInternational journal of general medicine2025
Insulin Resistance as a Biomarker for Pelvic Organ Prolapse in Gestational Diabetes Mellitus: Stratification by Delivery Modes.
Article in International journal of general medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: This study was to observe the assessment value of insulin and insulin resistance level on pelvic organ prolapse (POP) in women with gestational diabetes mellitus (GDM) who experienced different delivery modes, and to analyze the association between insulin and insulin resistance level and pelvic organ prolapse in GDM. Methods: 150 GDM patients were selected as the observation group, with 150 healthy pregnant women as the control group. PG and HOMA-IR levels were compared between groups. Correlation analysis was conducted with Pearson method. Logistic regression was used to analyze the relationship between serum insulin and insulin resistance levels and POP in patients with GDM. The value of serum insulin and insulin resistance levels in predicting POP in patients with GDM was analyzed by ROC curves, and area under the curve (AUC) was compared by the Z test. Results: POP was detected in 148 out of 300 cases (49.3%), with a prevalence of 62.0% in the GDM group compared to 36.7% in the control group. PG and HOMA-IR levels were higher in GDM patients with POP. BMI ≥ 24 kg/m Conclusion: Insulin and insulin resistance levels are associated with POP in women with GDM with different modes of delivery, and their combined assessment may increase the predictive value for POP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.